Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy

Platinum-based chemotherapy remains the cornerstone of treatment for most non-small cell lung cancer (NSCLC) cases either as maintenance therapy or in combination with immunotherapy. However, resistance remains a primary issue. Our findings point to the possibility of exploiting levels of cell divis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Commun Biol
Autors principals: Kildey, Katrina, Gandhi, Neha S., Sahin, Katherine B., Shah, Esha T., Boittier, Eric, Duijf, Pascal H. G., Molloy, Christopher, Burgess, Joshua T., Beard, Sam, Bolderson, Emma, Suraweera, Amila, Richard, Derek J., O’Byrne, Kenneth J., Adams, Mark N.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8163776/
https://ncbi.nlm.nih.gov/pubmed/34050247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-021-02136-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars